Home>Topics>Stocks>NPS Pharmaceuticals

NPS Pharmaceuticals NPSP

  1. All
  2. Commentary
  3. Headlines
    1. Shire Fourth Quarter In-Line; Guidance a Bit Soft due to Currency Impacts; Shares Fairly Valued

      Commentary

      Thu, 12 Feb 2015

      impacts. We think the company's growth by acquisition strategy, such as its recent $5.2 billion purchase of NPS Pharmaceuticals , reinforces Shire's narrow economic moat, as the deal adds new drugs to its growing rare disease portfolio and leverages

    2. Shire shares jump as drug approval vindicates $5.2 bln NPS purchase

      Headlines

      Mon, 26 Jan 2015

      LONDON, Jan 26 (Reuters) - Shire Plc shares gained more than 3 percent on Monday following news U.S. regulators had approved NPS Pharmaceuticals Inc's drug Natpara, validating Shire's decision to buy...

    3. UPDATE 1-U.S. FDA approves NPS drug, in move validating Shire takeover deal

      Headlines

      Fri, 23 Jan 2015

      Jan 23 (Reuters) - The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc's drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed to acquire NPS for $5.2 billion.

    4. FDA approves NPS drug, in move validating Shire takeover deal

      Headlines

      Fri, 23 Jan 2015

      Jan 23 (Reuters) - The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc.'s drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed...

    5. Rise in healthcare stocks lifts European equities

      Headlines

      Mon, 12 Jan 2015

      LONDON, Jan 12 (Reuters) - A rise in healthcare shares, following renewed signs of industry consolidation after Shire Plc agreed to buy NPS Pharmaceuticals for $5.2 billion, lifted European equities...

    6. Shire’s Acquisition of NPS Pharma Adds to its Moaty Rare Disease Portfolio; Increasing FVE Modestly

      Commentary

      Sun, 11 Jan 2015

      We anticipate increasing Shire’s FVE by about 5% following its agreement to acquire NPS Pharmaceuticals for $5.2 billion in cash (or $46 per share). We think it reinforces Shire's narrow economic moat, as the deal will add

    7. Deals of the day- Mergers and acquisitions

      Headlines

      Mon, 5 Jan 2015

      (Adds NPS Pharmaceuticals , Revel Casino Hotel, Bang & Olufsen, Energy Fuels)

    8. FDA extends review date for NPS Pharma hormone replacement therapy

      Headlines

      Thu, 23 Oct 2014

      Oct 23 (Reuters) - NPS Pharmaceuticals Inc said the U.S. Food and Drug Administration had extended the review date for its hormone replacement therapy by three months to provide time for a full...

    9. Five Things You Should Know About U.S. Small-Caps

      Headlines

      Mon, 20 Oct 2014

      NPS Pharmaceuticals NPSP raised $50 million Monday through the sale of its Preotact royalty stream to Drug Royalty Corporation. We're maintaining our

    10. Sell-Off in Health Care Sector Overlooks Strong Fundamentals

      Headlines

      Fri, 25 Apr 2014

      Pharmaceuticals International, Inc. (U.S. Shares) (2.19%), AstraZeneca PLC (ADR) (1.78%) and NPS Pharmaceuticals , Inc. (1.74%). There are no assurances that any Janus portfolio currently holds these securities or other

    « Prev123Next »
    Content Partners